{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:22:12Z","timestamp":1780525332788,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T00:00:00Z","timestamp":1420761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T00:00:00Z","timestamp":1420761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep07705","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T10:15:07Z","timestamp":1420798507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Plasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degeneration"],"prefix":"10.1038","volume":"5","author":[{"given":"Fuxiang","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nagasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Nagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Senga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,9]]},"reference":[{"key":"BFsrep07705_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0039-6257(03)00030-4","volume":"48","author":"J Ambati","year":"2003","unstructured":"Ambati, J. et al. Age-related macular degeneration: etiology, pathogenesis and therapeutic strategies. Surv Ophthalmol 48, 257\u2013293 (2003).","journal-title":"Surv Ophthalmol"},{"key":"BFsrep07705_CR2","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1172\/JCI42437","volume":"120","author":"AC Bird","year":"2010","unstructured":"Bird, A. C. Therapeutic targets in age-related macular disease. J Clin Invest 120, 3033\u20133041 (2010).","journal-title":"J Clin Invest"},{"key":"BFsrep07705_CR3","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1056\/NEJMra062326","volume":"355","author":"PTVM de Jong","year":"2006","unstructured":"de Jong, P. T. V. M. Mechanisms of disease: Age-related macular degeneration. New Engl J Med 355, 1474\u20131485 (2006).","journal-title":"New Engl J Med"},{"key":"BFsrep07705_CR4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown, D. M. et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. New Engl J Med 355, 1432\u20131444 (2006).","journal-title":"New Engl J Med"},{"key":"BFsrep07705_CR5","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"ES Gragoudas","year":"2004","unstructured":"Gragoudas, E. S., Adamis, A. P., Cunningham Jr, E. T., Feinsod, M. & Guyer, D. R. Pegaptanib for neovascular age-related macular degeneration. New Engl J Med 351, 2805\u20132816 (2004).","journal-title":"New Engl J Med"},{"key":"BFsrep07705_CR6","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld, P. J. et al. Ranibizumab for neovascular age-related macular degeneration. New Engl J Med 355, 1419\u20131431 (2006).","journal-title":"New Engl J Med"},{"key":"BFsrep07705_CR7","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1111\/bph.12737","volume":"171","author":"H Kaneko","year":"2014","unstructured":"Kaneko, H. et al. Histamine receptor h4 as a new therapeutic target for choroidal neovascularization in age-related macular degeneration. Br J Pharmacol 171, 3754\u20133763 (2014).","journal-title":"Br J Pharmacol"},{"key":"BFsrep07705_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature08151","volume":"460","author":"A Takeda","year":"2009","unstructured":"Takeda, A. et al. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460, 225\u2013230 (2009).","journal-title":"Nature"},{"key":"BFsrep07705_CR9","doi-asserted-by":"crossref","unstructured":"Fridman, A. Plasma chemistry. (Cambridge University Press, 2008).","DOI":"10.1017\/CBO9780511546075"},{"key":"BFsrep07705_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4012\/dmj.2010-190","volume":"30","author":"H Yamazaki","year":"2011","unstructured":"Yamazaki, H. et al. Microbicidal activities of low frequency atmospheric pressure plasma jets on oral pathogens. Dent Mater J 30, 384\u2013391 (2011).","journal-title":"Dent Mater J"},{"key":"BFsrep07705_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ppap.200700154","volume":"5","author":"G Fridman","year":"2008","unstructured":"Fridman, G. et al. Applied plasma medicine. Plasma Process Polym 5, 503\u2013533 (2008).","journal-title":"Plasma Process Polym"},{"key":"BFsrep07705_CR12","doi-asserted-by":"publisher","first-page":"115011","DOI":"10.1088\/1367-2630\/11\/11\/115011","volume":"11","author":"G Morfill","year":"2009","unstructured":"Morfill, G., Kong, M. G. & Zimmermann, J. Focus on plasma medicine. New J Phys 11, 115011 (2009).","journal-title":"New J Phys"},{"key":"BFsrep07705_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/fcp.12018","volume":"28","author":"M Yousfi","year":"2014","unstructured":"Yousfi, M., Merbahi, N., Pathak, A. & Eichwald, O. Low-temperature plasmas at atmospheric pressure: toward new pharmaceutical treatments in medicine. Fundam Clin Pharmacol 28, 123\u2013135 (2014).","journal-title":"Fundam Clin Pharmacol"},{"key":"BFsrep07705_CR14","doi-asserted-by":"publisher","first-page":"e33245","DOI":"10.1371\/journal.pone.0033245","volume":"7","author":"P Brun","year":"2012","unstructured":"Brun, P. et al. Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma. PLoS One 7, e33245 (2012).","journal-title":"PLoS One"},{"key":"BFsrep07705_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11090-006-9024-4","volume":"26","author":"G Fridman","year":"2006","unstructured":"Fridman, G. et al. Blood coagulation and living tissue sterilization by floating-electrode dielectric barrier discharge in air. Plasma Chem Plasma Process 26, 425\u2013442 (2006).","journal-title":"Plasma Chem Plasma Process"},{"key":"BFsrep07705_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.joen.2009.01.008","volume":"35","author":"HW Lee","year":"2009","unstructured":"Lee, H. W. et al. Tooth bleaching with nonthermal atmospheric pressure plasma. J Endod 35, 587\u2013591 (2009).","journal-title":"J Endod"},{"key":"BFsrep07705_CR17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jbiotec.2010.10.003","volume":"150","author":"C-H Kim","year":"2010","unstructured":"Kim, C.-H. et al. Induction of cell growth arrest by atmospheric non-thermal plasma in colorectal cancer cells. J Biotechnol 150, 530\u2013538 (2010).","journal-title":"J Biotechnol"},{"key":"BFsrep07705_CR18","doi-asserted-by":"publisher","first-page":"372001","DOI":"10.1088\/0022-3727\/44\/37\/372001","volume":"44","author":"T Sato","year":"2011","unstructured":"Sato, T., Yokoyama, M. & Johkura, K. A key inactivation factor of HeLa cell viability by a plasma flow. J Phys D Appl Phys 44, 372001 (2011).","journal-title":"J Phys D Appl Phys"},{"key":"BFsrep07705_CR19","doi-asserted-by":"publisher","first-page":"e81576","DOI":"10.1371\/journal.pone.0081576","volume":"8","author":"F Utsumi","year":"2013","unstructured":"Utsumi, F. et al. Effect of Indirect Nonequilibrium Atmospheric Pressure Plasma on Anti-Proliferative Activity against Chronic Chemo-Resistant Ovarian Cancer Cells In Vitro and In Vivo. PLoS One 8, e81576 (2013).","journal-title":"PLoS One"},{"key":"BFsrep07705_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ppap.200900080","volume":"7","author":"M Vandamme","year":"2010","unstructured":"Vandamme, M. et al. Antitumor effect of plasma treatment on U87 glioma xenografts: preliminary results. Plasma Process Polym 7, 264\u2013273 (2010).","journal-title":"Plasma Process Polym"},{"key":"BFsrep07705_CR21","unstructured":"Torii, K. et al. Effectiveness of plasma treatment on gastric cancer cells. Gastric Cancer 6, 10.1007\/s10120-014-0395-6 (2014)."},{"key":"BFsrep07705_CR22","doi-asserted-by":"publisher","first-page":"081503","DOI":"10.1063\/1.2885084","volume":"92","author":"M Iwasaki","year":"2008","unstructured":"Iwasaki, M. et al. Nonequilibrium atmospheric pressure plasma with ultrahigh electron density and high performance for glass surface cleaning. Appl Phys Lett 92, 081503 (2008).","journal-title":"Appl Phys Lett"},{"key":"BFsrep07705_CR23","doi-asserted-by":"publisher","first-page":"026101","DOI":"10.1143\/APEX.4.026101","volume":"4","author":"F Jia","year":"2011","unstructured":"Jia, F. et al. Laser scattering diagnosis of a 60-hz non-equilibrium atmospheric pressure plasma jet. Appl Phys Express 4, 026101 (2011).","journal-title":"Appl Phys Express"},{"key":"BFsrep07705_CR24","doi-asserted-by":"publisher","first-page":"113702","DOI":"10.1063\/1.3694928","volume":"100","author":"S Iseki","year":"2012","unstructured":"Iseki, S. et al. Selective killing of ovarian cancer cells through induction of apoptosis by nonequilibrium atmospheric pressure plasma. Appl Phys Lett 100, 113702\u2013113704 (2012).","journal-title":"Appl Phys Lett"},{"key":"BFsrep07705_CR25","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1167\/iovs.10-6737","volume":"52","author":"D Tomida","year":"2011","unstructured":"Tomida, D. et al. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin. Invest Ophthalmol Vis Sci 52, 3193\u20133199 (2011).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep07705_CR26","doi-asserted-by":"publisher","first-page":"e13493","DOI":"10.1371\/journal.pone.0013493","volume":"5","author":"KM Nishiguchi","year":"2010","unstructured":"Nishiguchi, K. M., Kataoka, K., Kachi, S., Komeima, K. & Terasaki, H. Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate. PLoS One 5, e13493 (2010).","journal-title":"PLoS One"},{"key":"BFsrep07705_CR27","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1167\/iovs.08-1738","volume":"49","author":"H Kaneko","year":"2008","unstructured":"Kaneko, H., Nishiguchi, K. M., Nakamura, M., Kachi, S. & Terasaki, H. Characteristics of bone marrow-derived microglia in the normal and injured retina. Invest Ophthalmol Vis Sci 49, 4162\u20134168 (2008).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep07705_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","volume":"11","author":"V Tarallo","year":"2012","unstructured":"Tarallo, V. et al. DICER1 Loss and <i>Alu<\/i> RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88. Cell 11, 847\u2013859 (2012).","journal-title":"Cell"},{"key":"BFsrep07705_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/mt.2011.212","volume":"20","author":"ME Kleinman","year":"2011","unstructured":"Kleinman, M. E. et al. Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol Ther 20, 101\u2013108 (2011).","journal-title":"Mol Ther"},{"key":"BFsrep07705_CR30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1167\/iovs.06-0845","volume":"48","author":"K Miyata","year":"2007","unstructured":"Miyata, K. et al. Reduction of oscillatory potentials and photopic negative response in patients with autosomal dominant optic atrophy with OPA1 mutations. Invest Ophthalmol Vis Sci 48, 820\u2013824 (2007).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep07705_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ajpath.2012.10.012","volume":"182","author":"T Ito","year":"2012","unstructured":"Ito, T. et al. Girdin and its Phosphorylation Dynamically Regulate Neonatal Vascular Development and Pathological Neovascularization in the Retina. Am J Pathol 182, 586\u2013596 (2012).","journal-title":"Am J Pathol"},{"key":"BFsrep07705_CR32","doi-asserted-by":"publisher","first-page":"e35513","DOI":"10.1371\/journal.pone.0035513","volume":"7","author":"HK Bid","year":"2012","unstructured":"Bid, H. K. et al. Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12. PLoS One 7, e35513 (2012).","journal-title":"PLoS One"},{"key":"BFsrep07705_CR33","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood-2014-04-569566","volume":"124","author":"J Palomero","year":"2014","unstructured":"Palomero, J. et al. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma. Blood 124, 2235\u20132247 (2014).","journal-title":"Blood"},{"key":"BFsrep07705_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1098\/rsif.2011.0220","volume":"9","author":"KP Arjunan","year":"2012","unstructured":"Arjunan, K. P. et al. Non-thermal dielectric barrier discharge plasma induces angiogenesis through reactive oxygen species. J Roy Soc Interface 9, 147\u2013157 (2012).","journal-title":"J Roy Soc Interface"},{"key":"BFsrep07705_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0014-4835(03)00023-X","volume":"76","author":"F-Q Liang","year":"2003","unstructured":"Liang, F.-Q. & Godley, B. F. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 76, 397\u2013403 (2003).","journal-title":"Exp Eye Res"},{"key":"BFsrep07705_CR36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/archopht.1995.01100060136048","volume":"113","author":"JW Miller","year":"1995","unstructured":"Miller, J. W. et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 113, 810\u2013818 (1995).","journal-title":"Arch Ophthalmol"},{"key":"BFsrep07705_CR37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/lsm.20345","volume":"38","author":"N Solban","year":"2006","unstructured":"Solban, N. et al. Targeted photodynamic therapy. Lasers Surg Med 38, 522\u2013531 (2006).","journal-title":"Lasers Surg Med"},{"key":"BFsrep07705_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.taap.2005.07.018","volume":"212","author":"SH Oh","year":"2006","unstructured":"Oh, S. H. & Lim, S. C. A rapid and transient ROS generation by cadmium triggers apoptosis via caspase-dependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase upregulation. Toxicol. Appl. Pharmacol 212, 212\u2013223 (2006).","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"BFsrep07705_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s000180300001","volume":"60","author":"M Zafarullah","year":"2003","unstructured":"Zafarullah, M. et al. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60, 6\u201320 (2003).","journal-title":"Cell Mol Life Sci"},{"key":"BFsrep07705_CR40","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3109\/02713683.2010.500112","volume":"35","author":"R Hara","year":"2010","unstructured":"Hara, R. et al. Suppression of choroidal neovascularization by N-acetyl-cysteine in mice. Curr Eye Res 35, 1012\u20131020 (2010).","journal-title":"Curr Eye Res"},{"key":"BFsrep07705_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2353\/ajpath.2010.090604","volume":"177","author":"H Lei","year":"2010","unstructured":"Lei, H. et al. N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy. Am J Pathol 177, 132\u2013140 (2010).","journal-title":"Am J Pathol"},{"key":"BFsrep07705_CR42","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1073\/pnas.0909276107","volume":"107","author":"F Lebrun-Julien","year":"2010","unstructured":"Lebrun-Julien, F. et al. ProNGF induces TNF\u03b1-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway. Proc Natl Acad Sci U S A 107, 3817\u20133822 (2010).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep07705_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0042-6989(85)90076-8","volume":"25","author":"S Remtulla","year":"1985","unstructured":"Remtulla, S. & Hallett, P. A schematic eye for the mouse and comparisons with the rat. Vision Res 25, 21\u201331 (1985).","journal-title":"Vision Res"},{"key":"BFsrep07705_CR44","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1017\/S0952523805225129","volume":"22","author":"S Sharma","year":"2005","unstructured":"Sharma, S. et al. Pharmacological studies of the mouse cone electroretinogram. Vis Neurosci 22, 631\u2013636 (2005).","journal-title":"Vis Neurosci"},{"key":"BFsrep07705_CR45","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1167\/iovs.05-1118","volume":"47","author":"D-Y Yu","year":"2006","unstructured":"Yu, D.-Y. & Cringle, S. J. Oxygen distribution in the mouse retina. Invest Ophthalmol Vis Sci 47, 1109\u20131112 (2006).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep07705_CR46","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1136\/bjo.2006.102293","volume":"90","author":"S Michels","year":"2006","unstructured":"Michels, S. Is intravitreal bevacizumab (Avastin) safe? Br J Ophthalmol 90, 1333\u20131334 (2006).","journal-title":"Br J Ophthalmol"},{"key":"BFsrep07705_CR47","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s00125-008-0989-9","volume":"51","author":"R Sim\u00f3","year":"2008","unstructured":"Sim\u00f3, R. & Hern\u00e1ndez, C. Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 51, 1574\u20131580 (2008).","journal-title":"Diabetologia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep07705.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07705","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07705.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:27:57Z","timestamp":1672954077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep07705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,7,15]]}},"alternative-id":["BFsrep07705"],"URL":"https:\/\/doi.org\/10.1038\/srep07705","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,9]]},"assertion":[{"value":"23 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7705"}}